EUVIMED · CrossrefJournal
Liver International
ISSN 1478-3223 · Wiley
Latest articles
Issue Information
Enhanced Liver Fibrosis ( ELF ) and the Pursuit of Precision Hepatology in MASLD : Reply to Fouad and AbdAllah
TTK Promotes Hepatic Fibrosis Through PKM2 / H3T11 ‐Mediated GLS1 ‐Dependent Glutamine Catabolism
A Direct Comparison of Early and Late Washout in Hepatocellular Carcinoma Prognosis
Increased Hepatitis D Testing in Canada Identifies More HDV ‐Positive Individuals: A Multi‐Provincial Analysis, 2022–2024
Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol‐Associated Liver Disease
Spatial Acid‐Associated Niches Inform Irinotecan‐Based DEB ‐ TACE in Colorectal Liver Metastases: A Multicentre Randomized Trial
Reductions in Advanced Chronic Liver Disease Among People Who Inject Drugs: The ETHOS Engage Study
Body Adiposity as a Risk Factor for Portal Vein Thrombosis in Patients With Cirrhosis
Ketogenic Diet Effects on Liver Health in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Systematic Review
Comment on ‘Haemostatic Balance and Transfusion Strategies in Acute Liver Failure and Acute‐on‐Chronic Liver Failure: A Systematic Review’
Liver Injury Due to Hormonal Contraceptives in the Modern Era
Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
RNF216 Drives Hepatocellular Carcinoma Progression by Ubiquitin‐Dependent Degradation of the Tumour Suppressor CYLD
Prediction Beyond Established Models in Steatotic Liver Disease: Which New Predictors Add Value?
Radiation‐Induced Liver Disease: From Mechanistic Paradigms to Systems‐Level Prevention and Management
The Nucleoside Analogue NITD008 , Alone or Combined With Ribavirin, Potently Reduces Hepatitis E Virus Infection in Humanised Mice
Clinical Impact of the AISF STEPS ‐ MASH Algorithm: Real‐World Application in Tertiary Hepatology Practice
Comment on ‘Diagnostic Value and Influencing Factors of Ultrasound‐Derived Fat Fraction for Quantifying MASLD in Children’
Porto‐Sinusoidal Vascular Disorder and Sinusoidal Obstructive Syndrome Might Have Similar Pathogenesis and Clinical Presentation
Spleen Stiffness Dynamics Linking Acute Haemodynamic Response to Longitudinal Risk Assessment
Response to the Letter Regarding the ALPS ‐ HCC Score for Hepatocellular Carcinoma Risk Prediction
Comment on ‘Sarcopenia and Absolute Risk Prediction After Portosystemic Shunting in Older Adults’
High Subcutaneous Adipose Tissue Density Reflects Impaired Nutritional and Functional Reserve in Liver Transplant Candidates
Response to Liu Fangfang on ‘Haemostatic Balance and Transfusion Strategies in ALF and ACLF: A Systematic Review’
Response to He: Exposure Timing and Causal Interpretation in Competing‐Risk Analyses of Metformin and Hepatocellular Carcinoma
Haemodynamic Targets and Subsequent Management of 7‐mm TIPS
From Risk Stratification to Surveillance Decisions: Interpreting aMAP in Steatotic Liver Disease
Living Liver Donors Might Have Steatohepatitis and Hepatocellular Carcinoma Even 10 Years After Donation
Reply to Comments to Diagnostic Value and Influencing Factors of Ultrasound‐Derived Fat Fraction for Quantifying MASLD in Children
EUVIMED